These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 262085)

  • 1. Amelioration of splanchnic artery occlusion (SAO) shock by cysteine.
    Galvin MJ; Lefer AM
    Adv Shock Res; 1978; 1():261-70. PubMed ID: 262085
    [No Abstract]   [Full Text] [Related]  

  • 2. Beneficial mechanisms of action of a prostacyclin enhancing agent in splanchnic artery occlusion shock.
    Aoki N; Siegfried M; Tsao P; Lento P; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1988 Jun; 60(3):275-89. PubMed ID: 3175328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of adenosine, an adenosine-A1 antagonist, and their combination in splanchnic occlusion shock in rats.
    Karasawa A; Rochester JA; Lefer AM
    Circ Shock; 1992 Feb; 36(2):154-61. PubMed ID: 1582007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effect of anisodamine in hemorrhagic shock.
    Su J; Hock CE; Lefer AM
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):360-5. PubMed ID: 6728045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock.
    Aoki N; Johnson G; Lefer AM
    Am J Physiol; 1990 Feb; 258(2 Pt 1):G275-81. PubMed ID: 2305894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of prostaglandin F2alpha during splanchnic artery occlusion shock.
    Flynn JT; Bridenbaugh GA; Lefer AM
    Am J Physiol; 1976 Mar; 230(3):684-90. PubMed ID: 1266970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of endothelial damage and systemic shock by benidipine, a calcium antagonist, in rats subjected to splanchnic ischemia and reperfusion.
    Karasawa A; Rochester JA; Ma XL; Lefer AM
    Circ Shock; 1991 Mar; 33(3):135-41. PubMed ID: 2044207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of transforming growth factor-beta and tissue plasminogen activator in splanchnic artery occlusion and reperfusion in cats.
    Karasawa A; Guo JP; Ma XL; Lefer AM
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):95-105. PubMed ID: 1719297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-shock effects of human superoxide dismutase in splanchnic artery occlusion (SAO) shock.
    Bitterman H; Aoki N; Lefer AM
    Proc Soc Exp Biol Med; 1988 Jul; 188(3):265-71. PubMed ID: 3393543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of thromboxane receptor blockade in splanchnic artery occlusion shock.
    Aoki N; Lefer AM
    Methods Find Exp Clin Pharmacol; 1988 Jul; 10(7):413-8. PubMed ID: 3419244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salutary effects of nitrendipine, a new calcium entry blocker, in hemorrhagic shock.
    Hock CE; Su JY; Lefer AM
    Eur J Pharmacol; 1984 Jan; 97(1-2):37-46. PubMed ID: 6698110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of AVP in maintenance of circulatory homeostasis during hemorrhagic shock.
    Hock CE; Su JY; Lefer AM
    Am J Physiol; 1984 Feb; 246(2 Pt 2):H174-9. PubMed ID: 6696129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arachidonic acid in splanchnic artery occlusion shock.
    Bridenbaugh GA; Flynn JT; Lefer AM
    Am J Physiol; 1976 Jul; 231(1):112-9. PubMed ID: 961849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salutary effects of anisodamine in murine traumatic shock.
    Hock CE; Su JY; Lefer AM
    Circ Shock; 1983; 11(3):211-6. PubMed ID: 6652878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of prostacyclin and taprostene in splanchnic artery occlusion shock.
    VanAntwerp DR; Hedley LR; Spires DA; Strosberg AM; Johnson G; Lefer AM
    Eicosanoids; 1991; 4(1):15-20. PubMed ID: 2059456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of ethylketocyclazocine in hemorrhagic shock.
    Curtis MT; Lefer AM
    Adv Shock Res; 1983; 10():101-9. PubMed ID: 6308972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actions of dopamine in splanchnic artery occlusion shock.
    Galvin MJ; Lefer AM
    Am J Physiol; 1978 Jan; 234(1):H1-6. PubMed ID: 623270
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma activation during splanchnic arterial occlusion shock.
    Kistler EB; Lefer AM; Hugli TE; Schmid-Schönbein GW
    Shock; 2000 Jul; 14(1):30-4. PubMed ID: 10909890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
    Canale P; Squadrito F; Altavilla D; Ioculano M; Campo GM; Squadrito G; Urna G; Sardella A; Caputi AP
    Pharmacology; 1994 Dec; 49(6):376-85. PubMed ID: 7878075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of the specific thromboxane receptor antagonist (+)-S145Na in splanchnic artery occlusion shock in rats.
    Furlan LE; Johnson G; Siegfried M; Lefer AM
    J Pharmacol Exp Ther; 1990 May; 253(2):525-9. PubMed ID: 2140129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.